首页 >
法规速递
-
Document: European Medicines Agency pre-authorisation procedural advice for users of the centralised procedure-2025/3/25
2025-03-26查看详情 > -
Document: EudraVigilance Expert Working Group (EV-EWG) work programme 2025-2026-2025/4/28
2025-04-29查看详情 > -
Document: Minutes of the CHMP meeting 27-30 January 2025-2025/6/5
2025-06-06查看详情 > -
药你知道 | 《国家药监局关于发布优化全生命周期监管支持高端医疗器械创新发展有关举措的公告》系列解读（一）-2025/7/14
2025-07-15查看详情 > -
关于将ICP-723口崩片纳入《儿童抗肿瘤药物研发鼓励试点计划（星光计划）》试点项目的公示-2025/8/21
2025-08-22查看详情 > -
Document: Members of the Coordinating group of European network of paediatric research at the European Medicines Agency (Enpr-EMA)-2025/9/30
2025-10-08查看详情 > -
Page: CVMP recommendations on limited market classification and eligibility for authorisation under Article 23-2025/11/7
2025-11-10查看详情 > -
Document: Concept paper on the guideline revision on good pharmacogenomic practice-2025/12/8
2025-12-09查看详情 > -
Document: Briefing Document for Quality Innovation Group (QIG) 1-to-1 meeting-2026/1/15
2026-01-16查看详情 > -
国家药监局药审中心关于发布《研发期间安全性更新报告的问答文件》的通告（2026年第19号）-2026/2/24
2026-02-27查看详情 >
